🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eric A. Welsh

Moffitt Cancer Center

ORCID: 0000-0002-9302-3855

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization

Translational Oncology(2021)10.1016/j.tranon.2021.101165

Top 12%

1.7DataRank

Top 12%73 citations

Zhigang Yuan, Kamran A. Ahmed, Eric A. Welsh, William J. Fulp, Ricardo González +8 more

Papers

Driven by 15 papers — median percentile 88. Top paper: “Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization”.

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization

Translational Oncology(2021)10.1016/j.tranon.2021.101165

Top 12%

1.7DataRank

Top 12%73 citations

Zhigang Yuan, Kamran A. Ahmed, Eric A. Welsh, William J. Fulp, Ricardo González +8 more

Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2840

N/A

0DataRank · unranked

57 citations

Vincent Law, Clayton Wyatt, Brittany Evernden, Bin Fang, John M. Koomen +5 more

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability

Neoplasia(2021)10.1016/j.neo.2021.09.003

N/A

0DataRank · unranked

34 citations

G. Daniel Grass, Eric A. Welsh, Kamran A. Ahmed, Jamie K. Teer, Shari Pilon‐Thomas +7 more

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

Cell chemical biology(2021)10.1016/j.chembiol.2021.07.008

N/A

0DataRank · unranked

38 citations

Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, Silvia Novakova +10 more

Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4781

N/A

0DataRank · unranked

36 citations

Liwei Chen, Shengyan Xiang, Rajanikanth Vangipurapu, Hua Yang, Francisca Beato +11 more

Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0275

N/A

0DataRank · unranked

11 citations

Sina Hosseinian, Mia Stroud, Emma Adhikari, James J. Saller, Matthew A. Smith +14 more

Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102550

N/A

0DataRank · unranked

5 citations

Sweta Dash, Thales C. Nepomuceno, Bin Fang, Sang Y. Yun, Eric A. Welsh +6 more

Ovarian cancer: Age, prognosis, and biologic underpinnings.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17555

N/A

0DataRank · unranked

0 citations

Biwei Cao, Anders Berglund, Jing‐Yi Chern, Hye Sook Chon, Mihaela Cristea +13 more

MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0218

N/A

0DataRank · unranked

11 citations

Logan C. Tyler, Anh T. Le, Eric A. Welsh, Bin Fang, Andrew Elliott +7 more

Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2

Cell chemical biology(2023)10.1016/j.chembiol.2023.09.011

N/A

0DataRank · unranked

7 citations

Lily L. Remsing Rix, Xueli Li, Bin Fang, Victoria Izumi, Eric A. Welsh +6 more

Data from Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6530501

N/A

0DataRank · unranked

0 citations

Liwei Chen, Shengyan Xiang, Rajanikanth Vangipurapu, Hua Yang, Francisca Beato +11 more

A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention times

Metabolomics(2025)10.1007/s11306-025-02343-y

N/A

0DataRank · unranked

1 citations

Yonatan Ayalew Mekonnen, Isis Narváez-Bandera, Vanessa Rubio, Dalia Ercan, Eric A. Welsh +13 more

Reproducible Sectioning and Sample Preparation for Mass Spectrometry Imaging of Cancer Metabolism in Frozen Lung Tissue

Methods in molecular biology(2025)10.1007/978-1-0716-4534-5_23

N/A

0DataRank · unranked

2 citations

Hayley D. Ackerman, Nicole Hackel, Christina L. Carr, Jaden R Baldwin, John H. Lockhart +10 more

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

PLoS ONE(2020)10.1371/journal.pone.0240849

N/A

0DataRank · unranked

28 citations

Irina Gaynanova, Steven A. Eschrich, Eric A. Welsh, Timothy J. Garrett, Chris Beecher +6 more

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology(2025)10.1002/1878-0261.70155

N/A

0DataRank · unranked

0 citations

Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo +9 more